ET
Equitable Trust Portfolio holdings
AUM
$2.01B
This Quarter Return
+11.01%
1 Year Return
+23.1%
3 Year Return
+77.46%
5 Year Return
+121.13%
10 Year Return
–
AUM
$1.27B
AUM Growth
+$1.27B
(+5.8%)
Cap. Flow
-$36.3M
Cap. Flow
% of AUM
-2.86%
Top 10 Holdings %
Top 10 Hldgs %
31.4%
Holding
427
New
45
Increased
91
Reduced
175
Closed
38
Top Buys
| 1 |
iShares Gold Trust
IAU
|
$28.1M |
| 2 |
Labcorp
LH
|
$13.2M |
| 3 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
$10.1M |
| 4 |
VanEck Gold Miners ETF
GDX
|
$9.67M |
| 5 |
Otis Worldwide
OTIS
|
$6.08M |
Top Sells
Sector Composition
| 1 | Technology | 15.96% |
| 2 | Healthcare | 12.68% |
| 3 | Financials | 12.52% |
| 4 | Industrials | 8.02% |
| 5 | Consumer Discretionary | 5.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Abbott
ABT
$230B
| $4.83M | 0.38% |
43,955
-21,887
| -33% | -$2.4M |
|
52
Salesforce
CRM
$245B
| $4.66M | 0.37% |
35,165
-41,958
| -54% | -$5.56M |
|
53
PepsiCo
PEP
$203B
| $4.55M | 0.36% |
25,196
+1,034
| +4% | +$187K |
|
54
ASML
ASML
$290B
| $4.39M | 0.35% |
8,028
-4,054
| -34% | -$2.22M |
|
55
Goldman Sachs
GS
$221B
| $4.33M | 0.34% |
12,607
-2,206
| -15% | -$757K |
|
56
Zoetis
ZTS
$67.6B
| $4.3M | 0.34% |
29,322
-13,375
| -31% | -$1.96M |
|
57
CSX Corp
CSX
$60.2B
| $4.24M | 0.33% |
136,728
| – | – |
|
58
Carlyle Group
CG
$22.9B
| $4.21M | 0.33% |
140,922
-59,748
| -30% | -$1.78M |
|
59
Vanguard International High Dividend Yield ETF
VYMI
$11.7B
| $4.19M | 0.33% |
70,383
+37,775
| +116% | +$2.25M |
|
60
AbbVie
ABBV
$374B
| $4.16M | 0.33% |
25,736
+890
| +4% | +$144K |
|
61
Caterpillar
CAT
$194B
| $3.94M | 0.31% |
16,463
-2,855
| -15% | -$684K |
|
62
lululemon athletica
LULU
$23.8B
| $3.9M | 0.31% |
12,170
-1,490
| -11% | -$477K |
|
63
Vulcan Materials
VMC
$38.1B
| $3.76M | 0.3% |
21,450
-4,527
| -17% | -$793K |
|
64
Ferrari
RACE
$88.2B
| $3.72M | 0.29% |
17,375
-1,763
| -9% | -$378K |
|
65
McDonald's
MCD
$226B
| $3.72M | 0.29% |
14,116
-165
| -1% | -$43.5K |
|
66
AstraZeneca
AZN
$255B
| $3.68M | 0.29% |
54,324
-8,521
| -14% | -$578K |
|
67
ResMed
RMD
$39.4B
| $3.67M | 0.29% |
17,648
-1,620
| -8% | -$337K |
|
68
Icon
ICLR
$14B
| $3.66M | 0.29% |
18,857
-11,980
| -39% | -$2.33M |
|
69
Northrop Grumman
NOC
$83.2B
| $3.66M | 0.29% |
6,711
| – | – |
|
70
Alcon
ALC
$38.9B
| $3.52M | 0.28% |
51,318
-6,675
| -12% | -$458K |
|
71
EOG Resources
EOG
$65.8B
| $3.35M | 0.26% |
25,894
-338
| -1% | -$43.8K |
|
72
Texas Pacific Land
TPL
$20.9B
| $3.34M | 0.26% |
1,425
-133
| -9% | -$312K |
|
73
Target
TGT
$42B
| $3.34M | 0.26% |
22,399
-1,879
| -8% | -$280K |
|
74
Pfizer
PFE
$141B
| $3.33M | 0.26% |
64,953
+1,876
| +3% | +$96.1K |
|
75
Berkshire Hathaway Class A
BRK.A
$1.08T
| $3.28M | 0.26% |
7
| – | – |
|